Navigation Links
Researchers genetically link Lou Gehrig's disease in humans to dog disease
Date:1/21/2009

COLUMBIA, Mo. An incurable, paralyzing disease in humans is now genetically linked to a similar disease in dogs. Researchers from the University of Missouri and the Broad Institute have found that the genetic mutation responsible for degenerative myelopathy (DM) in dogs is the same mutation that causes amyotrophic lateral sclerosis (ALS), the human disease also known as Lou Gehrig's Disease. As a result of the discovery, which will be published in the Proceedings of the National Academy of Sciences this week, researchers can now use dogs with DM as animal models to help identify therapeutic interventions for curing the human disease, ALS.

"We uncovered the genetic mutation of degenerative myelopathy, which has been unknown for 30 years, and linked it to ALS, a human disease that has no cure," said Joan Coates, a veterinary neurologist and associate professor of veterinary medicine and surgery in the MU College of Veterinary Medicine. "Dogs with DM are likely to provide scientists with a more reliable animal model for ALS. Also, this discovery will pave the way for DNA tests that will aid dog breeders in avoiding DM in the future."

Previously, ALS research has relied heavily on transgenic rodents that expressed the mutant human gene SOD1, which causes ALS. Researchers found that dogs with DM also had mutations in their SOD1 gene. Many rodent models possess very high levels of the SOD1 protein that can produce pathologic processes distinct from those occurring in ALS patients. Since the SOD1 mutation is spontaneous in dogs, the clinical spectrum in dogs may represent more accurately that of human ALS.

"Compared with the rodent models for ALS, dogs with DM are more similar to people in size, structure and complexity of their nervous systems, and duration of the disease," said Gary Johnson, associate professor of veterinary pathobiology in the MU College of Veterinary Medicine. "The results from clinical trials conducted w
'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Texas Medical Center researchers win collaborative grants
2. Researchers describe protease inhibitor that may aid in diabetic retinopathy treatment
3. Researchers examine developing hearts in chickens to find solutions for human heart abnormalities
4. JDRF-funded researchers discover proteins regulating human beta cell replication
5. Researchers to use K-States BSL-3 Lab for $1 million study of fungus threatening wheat crops
6. Researchers identify potential new weapon in battle against HIV infection
7. U-M researchers discover new genes that fuse in cancer
8. Researchers first to see reactive oxygen species in vital enzyme
9. Dartmouth researchers find new protein function
10. Burnham researchers discover on switch for cell death signaling mechanism
11. Salk researchers develop novel glioblastoma mouse model

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ple who smoke their first cigarette within minutes...ne, a by-product of nicotine when processed by the... the number of cigarettes smoked. , "Since co...ancer, our results suggest that smokers who smoke ... for lung cancer," said researcher Joshua E. Musca...
(Date:12/2/2009)...osure to secondhand smoke for a prolonged period o...of breast cancer, even in women who never smoked c...r exposure to side-stream smoke could increase ris...d Peggy Reynolds, Ph.D., senior research scientist...ey office. "While no single epidemiologic study ca...
(Date:12/2/2009)...╤ A Smoky Mountain forest,s woodland herb po... how forest understories recover from logging, acc...heavy logging in portions of the forest nearly 80 ...the secondary forest floor was similar to that of ...tant professor of forestry and natural resources, ...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 1Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 2Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 3NewLink Genetics Corporation Closes 247 5 Million Financing 13102 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 3
...al/ethnic groups examined, Hispanic women were fou...sociated gene mutation BRCA1 at 3.5 percent, with ...percent), according to a study in the December 26 ...or gene BRCA1 confer high risks of breast and ovar...s has been estimated at 65 percent for breast canc...
...from their leaves to flowers, roots, fruits and ot...ering techniques, Cornell researchers have finally..., The findings not only deepen understanding of ba...ers to genetically engineer plants with increased ...take. This might be critically important in an era...
...iety has announced the winners of its internationa... Biophysical Society and the International Biophys...-6, 2008. The purpose of these awards is to foste...n biophysicists and scientists working in countrie... of this competitive award are chosen based on sci...
Other Biology News:Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer 2Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer 3Cornell researchers prove how plants transport sugars 2Biophysical Society announces 2008 International Travel Awards 2Biophysical Society announces 2008 International Travel Awards 3Biophysical Society announces 2008 International Travel Awards 4Biophysical Society announces 2008 International Travel Awards 5Biophysical Society announces 2008 International Travel Awards 6Biophysical Society announces 2008 International Travel Awards 7
(Date:12/3/2009)... , DALLAS, Dec. 3 ...rd: ACCP), today provided an update on its Europea...atment for oral mucositis, a debilitating side eff...d is commercially launched by Access, partner, Spe..., Germany, Italy, Norway, Greece and Sweden. Acces...
(Date:12/3/2009)..., TUSTIN, Calif., Dec. 3 /PRNewswire-FirstCall/... ) today announced that it will release its financ...2010 on December 10, 2009 at 7:00 a.m. EST and wil...e results at 11:30 a.m. EST on the same day. ,,...ial results for the second quarter ended October 3...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire-...ce Officer at Shenzhen Beike Biotechnology Co. Ltd...ference on High-Risk Diabetic,Foot Care in New Del...ding,stem cell research and regenerative medicine ...he Indian Podiatry Association (IPA), aimed,to hel...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Neurostimul.../www.reportlinker.com/p0164232/Neurostimulation---... neurostimulation market stands enthused by the gr...rise in age-related diseases such as, Parkinson,s,...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...c. (NYSE Alternext US: IMM.BC) today announced tha...ding (MOU) confirming its interest in exploring th... Pharmaceutical Group Co. Ltd. (BPGC). The MOU co...f collaborative global business development opport...est state-owned pharmaceutical and medical device ...
... million in Q4 2007 - a 4.0% increase , , Q4 200...n Q4 2007 - a 10.0% increase , , Q4 2008 New Book... - a 15.1% increase , , 2008 Net Revenues -- $133...rease , , 2008 Diluted Net Income per Share of $0... New Bookings of $187.2 million vs. $138.6 million...
... (NYSE: LMT ) has partnered with Penn State Uni...nergy sector. As part of the corporation,s commitm...s, Lockheed Martin will fund $400,000 of research ..., , Leveraging a partnership spanning more than 3... collaboration will focus on Smart Grid technolog...
Other Biology Technology:Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 2Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 3ERT Reports Fourth Quarter and Full Year 2008 Results 2ERT Reports Fourth Quarter and Full Year 2008 Results 3ERT Reports Fourth Quarter and Full Year 2008 Results 4ERT Reports Fourth Quarter and Full Year 2008 Results 5ERT Reports Fourth Quarter and Full Year 2008 Results 6ERT Reports Fourth Quarter and Full Year 2008 Results 7ERT Reports Fourth Quarter and Full Year 2008 Results 8ERT Reports Fourth Quarter and Full Year 2008 Results 9ERT Reports Fourth Quarter and Full Year 2008 Results 10ERT Reports Fourth Quarter and Full Year 2008 Results 11Lockheed Martin Invests in Smart Grid Research and Development at Penn State University 2
Anti-Human FADD, phospho (Ser194) Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Viral WNV Core Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse Anti-Human HSD17B3 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Rad51, N-terminal Antibody, Unconjugated from CHEMICON
Biology Products: